Integrating iquix, vigamox, and zymar in the management of ocular infectious disease.
McLeod
Stephen D
SD
University of California San Francisco School of Medicine, Department of Ophthalmology, San Francisco, CA 94143, USA.
D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015817:Eye Infections / Q000188:drug therapy*; D024841:Fluoroquinolones / Q000008:administration & dosage / Q000627:therapeutic use*; D000077734:Gatifloxacin; D006801:Humans; D009883:Ophthalmic Solutions; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009883:Ophthalmic Solutions; D000077734:Gatifloxacin